We are live on ! Find out more
CA

Cambridge Associates Portfolio holdings

AUM $6.93B
1-Year Est. Return 17.96%
This Fund
S&P 500
This Quarter Est. Return
+5.98%
1 Year Est. Return
+17.96%
3 Year Est. Return
+50.09%
5 Year Est. Return
+43.04%
10 Year Est. Return
+112.03%
AUM
$2.7B
AUM Growth
+$1.55B
Cap. Flow
+$1.47B
Cap. Flow %
54.26%
Top 10 Hldgs %
73.34%
Holding
53
New
3
Increased
44
Reduced
Closed
6

Sector Composition

Rank Sector Weight
1 Miscellaneous 98.61%
2 Industrials 1.32%
3 Healthcare 0.07%
4 Energy 0%
5 Technology 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EXE
51
Expand Energy Corp
EXE
$22.9B
-350,871
Closed -$46K
PLAN
52
DELISTED
Anaplan, Inc.
PLAN
-45,263
Closed -$2.76M
CSLT
53
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
-11,636
Closed -$18K

Similar funds

Cambridge Associates's Q4 2021 Portfolio in Review

As of Q4 2021, Cambridge Associates held 53 positions worth $2.7B, up 135% from $1.15B the previous quarter. Its ten largest holdings account for 73% of the portfolio.

Cambridge Associates deployed $1.47B of net new capital in Q4 2021, opening 3 new positions and adding to 44 existing holdings. Its largest new stake was RTX Corp: 315,305 shares worth $27.1M.

By sector, the portfolio is most concentrated in Miscellaneous at 99% of assets, down from 100% a quarter earlier, followed by Industrials and Healthcare.

On the sell side, the most notable exit was iShares US Treasury Bond ETF, an estimated $14.9M sold.

  • Cambridge Associates's largest Q4 2021 buy was RTX Corp: 315,305 shares worth $27.1M.
  • Cambridge Associates added most to Vanguard S&P 500 ETF in Q4 2021, an estimated $372M increase.
  • Cambridge Associates fully exited iShares US Treasury Bond ETF in Q4 2021, selling an estimated $14.9M.
  • Cambridge Associates's ten largest holdings make up 73% of its $2.7B portfolio in Q4 2021.
  • Cambridge Associates opened 3 new positions and closed 6 in Q4 2021.
  • Cambridge Associates's portfolio value rose 135% quarter-over-quarter to $2.7B.

Based on Cambridge Associates's 13F filing for Q4 2021, filed 11 Feb 2022.